The review discusses the key genetic drivers of pancreatic carcinogenesis, including KRAS, TP53, CDKN2A, SMAD4, and BRCA1/2, and emphasizes the role of these genes as therapeutic biomarkers for the development of targeted molecular therapy.
S. Kaviya, G. Sivakumar, P. Anandhasankar· International Journal of Inn...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.